Skip to content

Effect of transcutaneous acupoint electrical stimulation on recovery quality after laparoscopic hysterectomy: a randomized controlled trial

Effect of transcutaneous acupoint electrical stimulation on recovery quality after laparoscopic hysterectomy: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022064
Enrollment
Unknown
Registered
2019-03-23
Start date
2019-05-01
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic surgery

Interventions

control group:nil
TEAS group:transcutaneous acupoint electrical stimulation of lieque, neiguan and zusanli before and after surgery for 30 min

Sponsors

Baoding First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Postoperative laparoscopic hysterectomy in our hospital; 2. Aged 18-75 years; 3. ASA I~II; 4. BMI18-30.

Exclusion criteria

Exclusion criteria: 1. Participants who have contraindications in treatment with electrical stimulation such as local skin wound and infection,participants with a cardiac pacemaker; 2. Participants who refused to accept acupuncture, such as participants with psychological disorder and participants with inability to communicate; 3. Participants with a known history of alcohol or substance abuse; 4. Participants participating in another clinical trial in recent three months.

Design outcomes

Primary

MeasureTime frame
QoR15;

Secondary

MeasureTime frame
MAP, HR during surgery;VAS;analgesic drug comsuption;first flatus after surgery;Use of vasoactive drugs during operation;TNF-a;IL-1ß;IL-6;IL-10;DAO;D-LC;ZO-1;occludin;PONV;

Countries

Chna

Contacts

Public ContactZhao Xiaonan

Baoding First Central Hospital

zhaoxiaonan2005@126.com+86 15194969821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026